PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go:
17
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Cambridge Nutraceuticals develop and sell healthcare supplements that are proven to provide health benefits. Their products ar ecurrently on shelves in a number of the large high street retailers such as Holland & Barrett and Boots.
days to go:
Expired
investment:
£1,077,710
Genuine Impact is the next generation financial terminal made exclusively to empower DIY investors by providing experts with automation tools, portfolio enhancer, unbiased data and insights. Genuine Impact is more cost-effective in comparison with traditional financial terminals, and it makes financial research effortless and efficient. Currently, the company's beta app has 500+ users from more than 27 countries. With the proceeds, the fund raised will be used for new product development, enhancement of existing product and for marketing and branding.
days to go:
Expired
investment:
£500,920
Knoma is a payment solution that helps people looking to future-proof their career or move into new areas of work by eliminating the burden of upfront payment, and by removing the challenges of sourcing an appropriate course. Backed by a large European Venture Capital firm, Knoma enables lifelong learning as the global economy transitions to one where digital skills are essential for career success. All Knoma students can gain access up to £10,000 to pay for the course of their choice, which can be spread over 12 months with flexible repayments with no interest or fees applicable. The company has partnered with organisations like Codeclan, Wild Code School, Le Wagon, and Code Nation and has successfully secured £750,000 in funding from some of Europe's largest venture capital firms, namely, Global Founders Capital, and Rocket Internet. The company will utilise the investments to expand partnerships with tech and coding schools, test and deploy the Knoma app, unlock a £20 million debt facility to provide Knoma loans to its students, and scale the business on all verticals.
days to go:
Expired
investment:
£529,660
L.A Brewery (LAB) produces non-alcoholic kombucha made from health-boosting teas, fruits, and botanicals. LAB argues that 25% of drinkers consider themselves semi-regular consumers of low and no alcohol in the UK and aims to cater to the demands of this category. LAB asserts that it has already produced and sold one million drinks and achieved listings with entities like Amazon, Selfridges, Leon, Farmdrop, Wholefoods, Planet Organic, Ocado (March 2021), and 300+ independent stockists across the UK. It has also featured in Vogue, GQ, Tatler, Hello!, Elle, and Glamour, to name a few. LAB points out that its feature on ITV's 'Love Your Weekend' with Alan Titchmarsh resulted in £1,000+ worth of online sales in 10 minutes. It will use the investment to expand its microbrewery, increase production 4 times to meet future demand, and increase brand awareness.
days to go:
Expired
investment:
£1,349,997
